Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

10/8/24 4:54:00 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $TLPH alert in real time by email

SAN MATEO, Calif., Oct. 8, 2024 /PRNewswire/ -- Talphera, Inc. (NASDAQ:TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that management will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit and will be available for 1x1 meetings with registered investors. The summit is being held on October 15-17, 2024.

Event: 2024 Maxim Healthcare Virtual Summit

Date: October 16, 2024

Time: 3:00 PM ET / 12:00 Noon PT

Webcast link: 2024 Maxim Healthcare Virtual Summit

About Talphera, Inc.

Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA).

This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-participate-in-fireside-chat-at-the-2024-maxim-healthcare-virtual-summit-302270671.html

SOURCE Talphera, Inc.

Get the next $TLPH alert in real time by email

Date

Price Target

Rating

Analyst

1/28/2025

$4.00

Buy

Rodman & Renshaw

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

10/8/24 4:54:00 PM ET

$TLPH

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $TLPH alert in real time by email

Event: 2024 Maxim Healthcare Virtual Summit

Date: October 16, 2024

Time: 3:00 PM ET / 12:00 Noon PT

Webcast link: 2024 Maxim Healthcare Virtual Summit

This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-participate-in-fireside-chat-at-the-2024-maxim-healthcare-virtual-summit-302270671.html

SOURCE Talphera, Inc.

Get the next $TLPH alert in real time by email

Date

Price Target

Rating

Analyst

1/28/2025

$4.00

Buy

Rodman & Renshaw

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$TLPH

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$TLPH

$TLPH
Press Releases

Fastest customizable press release news feed in the world

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

$TLPH
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Medical Officer Aslam Shakil covered exercise/tax liability with 4,517 units of Commom Stock, decreasing direct ownership by 9% to 48,178 units (SEC Form 4)

Chief Medical Officer Aslam Shakil was granted 15,000 units of Commom Stock, increasing direct ownership by 40% to 52,695 units (SEC Form 4)

Chief Engineering Officer Dasu Badri N was granted 15,000 shares, increasing direct ownership by 56% to 42,011 units (SEC Form 4)

$TLPH
SEC Filings

Talphera Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

SEC Form 10-Q filed by Talphera Inc.

Talphera Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$TLPH
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

CHIEF EXECUTIVE OFFICER Angotti Vincent J. bought $125,000 worth of shares (213,310 units at $0.59) and was granted 61,000 shares, increasing direct ownership by 149% to 474,769 units (SEC Form 4)

Chief Medical Officer Aslam Shakil bought $6,038 worth of shares (5,695 units at $1.06), increasing direct ownership by 18% to 37,695 units (SEC Form 4)

CHIEF EXECUTIVE OFFICER Angotti Vincent J. bought $3,200 worth of shares (5,000 units at $0.64), increasing direct ownership by 2% to 208,066 units (SEC Form 4)

$TLPH
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Rodman & Renshaw initiated coverage on Talphera with a new price target

$TLPH
Financials

Live finance-specific insights

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

$TLPH
Leadership Updates

Live Leadership Updates

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for $TLPH

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for $TLPH

$TLPH Press Releases

Fastest customizable press release news feed in the world

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

$TLPH Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Medical Officer Aslam Shakil covered exercise/tax liability with 4,517 units of Commom Stock, decreasing direct ownership by 9% to 48,178 units (SEC Form 4)

Chief Medical Officer Aslam Shakil was granted 15,000 units of Commom Stock, increasing direct ownership by 40% to 52,695 units (SEC Form 4)

Chief Engineering Officer Dasu Badri N was granted 15,000 shares, increasing direct ownership by 56% to 42,011 units (SEC Form 4)

$TLPH SEC Filings

Talphera Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

SEC Form 10-Q filed by Talphera Inc.

Talphera Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$TLPH Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

CHIEF EXECUTIVE OFFICER Angotti Vincent J. bought $125,000 worth of shares (213,310 units at $0.59) and was granted 61,000 shares, increasing direct ownership by 149% to 474,769 units (SEC Form 4)

Chief Medical Officer Aslam Shakil bought $6,038 worth of shares (5,695 units at $1.06), increasing direct ownership by 18% to 37,695 units (SEC Form 4)

CHIEF EXECUTIVE OFFICER Angotti Vincent J. bought $3,200 worth of shares (5,000 units at $0.64), increasing direct ownership by 2% to 208,066 units (SEC Form 4)

$TLPH Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Rodman & Renshaw initiated coverage on Talphera with a new price target

$TLPH Financials

Live finance-specific insights

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

$TLPH Leadership Updates

Live Leadership Updates

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Recent Analyst Ratings for
$TLPH

Recent Analyst Ratings for
$TLPH

$TLPH
Press Releases

$TLPH
Insider Trading

$TLPH
SEC Filings

$TLPH
Insider Purchases

$TLPH
Analyst Ratings

$TLPH
Financials

$TLPH
Leadership Updates